Alyeska Investment Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $3.77M | Sell |
|
|||||
|
2025
Q1 | $22.8M | Sell |
|
|||||
|
2024
Q4 | $34M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $5.51M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $2.86M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $979K | Sell |
|
|||||
|
2017
Q1 | $1.42M | Sell |
|
|||||
|
2016
Q4 | $25M | Buy |
|
|||||
|
2016
Q3 | $22.3M | Sell |
|
|||||
|
2016
Q2 | $21M | Buy |
|
|||||
|
2016
Q1 | $13.5M | Buy |
|
|||||
|
2015
Q4 | $16.4M | Buy |
|